1124135

Gregory P. Kalemkerian, MD — FEI 3016839389

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 22, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ann Arbor, MI (United States)

Additional Details

Clinical Investigator (CI)